Company intelligence / Profile preview

ESW Vision

Houdan, France

Ownership: Private
Development stage: Other

Overview

ESW Vision, part of E-SWIN Group, develops and globally commercializes CE-marked and ISO 13485/MDSAP-certified ophthalmic devices such as E-Eye, tearstim, and tearcheck using proprietary IRPL (Intense Regulated Pulsed Light) technology and diagnostic imaging for the management of dry eye disease and meibomian gland dysfunction, with FDA clearance for some products and broad international registrations.[1][2][3][4]

Therapeutic areas: Ophthalmology
Modalities: DeviceNon-pharmacological therapy
Industry: Medical Imaging

Partnerships

I-MED Pharma (distribution partnership in North America, previously for the United States)[5]

Beyond the preview

Go deeper on ESW Vision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ESW Vision.

Explore the full profile